Thus, genetic elimination of Fap+ fibroblasts was associated with enhanced anti-cancer immunity and slower tumor growth in preclinical models of lung cancer [26], similar to phenotypes associated with Lrcc15+ CAFs. The gene discussed is FAP; the disease is cancer.